Phase I/II study of LY231514 [pemetrexed] plus cisplatin in patients with malignant pleural mesothelioma

Trial Profile

Phase I/II study of LY231514 [pemetrexed] plus cisplatin in patients with malignant pleural mesothelioma

Completed
Phase of Trial: Phase I/II

Latest Information Update: 27 Jan 2007

At a glance

  • Drugs Cisplatin; Pemetrexed
  • Indications Mesothelioma
  • Focus Adverse reactions; Therapeutic Use
  • Sponsors Eli Lilly
  • Most Recent Events

    • 27 Jan 2007 Status change
    • 24 Dec 2005 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top